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Abstract 
Aim: The aim of the present pilot study was to test whether a porcine collagenated 
bone substitute block (PCBB) and collagen membrane (CM) loaded with bone 
morphogenetic protein-2 (BMP-2) used for horizontal ridge augmentation differ from PCBB 
and CM without BMP-2 regarding the osseointegration of the grafting material and the 
maintenance of the ridge contour. 
Material & Methods: Two semi-saddle bone defects were created in each side of the 
mandible of 6 dogs. The defects were randomly allocated to receive one of the following 
treatments: bone augmentation using (1) PCBB, (2) PCBB loaded with BMP-2 (PCBB-
BMP2), (3) PCBB+CM, and (4) PCBB+CM loaded with BMP-2 (PCBB+CM-BMP2). After 12 
weeks, one titanium implant was inserted into every defect. After 8 weeks, one central 
histological section of each site was prepared. Histomorphometrical assessments were 
performed evaluating the augmented area (AA), the area of new bone (NB) (primary 
outcome), residual bone substitute (BS), and non-mineralized tissue (NMT) within AA in 
mm2. In addition, the most coronal and the most buccal localizations of new bone and 
residual bone substitute, and the most coronal bone-to-implant-contact were measured in 
mm. 
Results: Clinically, all PCBB were firmly integrated and permitted implant placement. 
All the implants osseointegrated and exhibited complete hard tissue coverage of the buccal 
surface. Bone ingrowth always reached the central portions of PCBB. AA measured 10.4±4.2 
mm2 for PCBB, 11.8±2.8 mm2 for PCBB-BMP2, 9.8±2.9 mm2 for PCBB+CM, and 8.5 ± 2.2 
mm2 for PCBB+CM-BMP2. Only the difference between PCBB-BMP2 and PCBB+CM-BMP2 
was statistically significant (P=0.031). NB reached 2.3±1.3 mm2 for PCBB, 2.0 ± 0.5 mm2 for 
PCBB-BMP2, 2.7±1.2 mm2 for PCBB+CM, and 1.8±0.7 mm2 for PCBB+CM-BMP2. There 
were no statistically significant differences regarding NB, the most coronal and the most 
buccal localizations of new bone, residual bone substitute, and bone-to-implant-contact 
(P>0.05). 
Conclusions:  The addition of BMP-2 to PCBB or CM used for horizontal ridge 
augmentation did not render a statistically significant improvement in the maintenance of the 
augmented ridge contour and the new bone formation. PCBB with and without CM showed 
pronounced bone ingrowth and capacity to maintain the augmented ridge contour. In all the 
regions previously augmented with PCBB, the implants successfully integrated and 
presented with complete hard tissue coverage.  
Introduction 
A prerequisite for long-term survival of dental implants is a sufficient amount of bone 
at the implant recipient site to allow osseointegration of the endosseous implant surface. 
Guided bone regeneration (GBR) with particulate xenogenic bone substitutes in combination 
with resorbable collagen membranes (CM) is currently the most widely used and well-
documented method used to augment bone in localized alveolar defects simultaneously to 
implant placement (Benic & Hammerle 2014; Chiapasco & Zaniboni 2009; Jensen & 
Terheyden 2009; Lee et al. 2015). In jaw regions with reduced ridge width precluding the 
primary stability of the implant in the prosthetically correct position, the staged approach for 
bone regeneration and implant placement is chosen. Autogenous bone blocks, alone, or in 
combination with particulate bone substitute and/or CM, are the most reliable and successful 
procedures for staged augmentations of large bone defects prior to implant placement 
(Jensen & Terheyden 2009; Klein & Al-Nawas 2011). However, morbidity and risk of 
complications related to the donor site, limited graft availability and unpredictable graft 
resorption are major limitations related to the use of autogenous bone (Cordaro et al. 2002; 
Cordaro et al. 2011; Johansson et al. 2001; Nkenke et al. 2001; von Arx et al. 2005; 
Widmark et al. 1997; Zeltner et al. 2016). 
To overcome these shortcomings, bone substitute blocks were developed as 
replacements to autogenous bone blocks for primary ridge augmentations procedures. 
Among different types of bone substitute blocks the research initially focused on the 
xenogenic materials. Several preclinical studies investigated the use of blocks of 
deproteinized bovine bone mineral (DBBM) for lateral (Araujo et al. 2002; Benic et al. 2016; 
De Santis et al. 2012; Schwarz et al. 2008) and vertical bone augmentation procedures 
(Schmitt et al. 2013; Simion et al. 2006). In other animal studies an equine-derived block of 
bone mineral containing collagen remnants was used for ridge augmentations of large 
defects (Benic et al. 2016; Fontana et al. 2008; Schwarz et al. 2010; Simion et al. 2009). 
These studies found that the block bone substitutes under investigation present scarce 
osteoconductive properties. In general, DBBM and equine blocks revealed poor bone 
ingrowth with little newly formed bone in the peripheral parts of the graft. The block materials 
were mostly embedded in fibrous tissue. 
Research has been directed toward growth factors, aiming at resolving the long 
treatment time and the limited predictability of bone regeneration at extensive bone defects 
(Reddi et al. 1987; Urist 1965). Various growth factors, including bone morphogenetic 
proteins (BMP), growth and differentiation factors (GDF), platelet-derived growth factor 
(PDGF), vascular endothelial growth factor (VEGF), insulin-like growth factor, peptides of the 
parathyroid hormone (PTH) and enamel matrix derivative, have been evaluated for bone 
regeneration procedures. A systematic review assessed the preclinical and human studies 
regarding clinical, histological and radiographic outcome of the use of growth factors for 
localized alveolar ridge augmentation (Jung et al. 2008). Different levels and quantity of 
evidence were available for the growth factors evaluated, revealing that BMP-2, BMP-7, 
GDF- 5, PDGF and PTH may stimulate local bone augmentation to various degrees. 
Although growth factors and xenograft blocks are available since several years, there is no 
clinical and scarce preclinical evidence for the use of growth factors in combination with 
xenogenic bone substitute blocks. Previous animal studies found pronounced 
osseointegration of the grafting material when DBBM blocks or equine blocks were loaded 
with PDGF, BMP-2 or GDF-5 (Schwarz et al. 2008; Simion et al. 2009; Simion et al. 2006). 
In contrast, in another investigation the osseointegration of DBBM blocks did not improve 
with the additional use of BMP-2 or VEGF (Schmitt et al. 2013). 
In the majority of the previous studies combining GBR with the application of growth 
factors, either a bone substitute or a resorbable collagen sponge were used as growth factor 
carriers. A graft-covering barrier membrane made of collagen can be considered an optional 
carrier of growth factors, since a membrane loaded with osteoinductive proteins might 
enhance the osteogenic potential of the periosteum in the mucoperiosteal flap. It was 
reported that the periosteum is highly osteogenic and rich in the mesenchymal cells that can 
differentiate into osteoblastic cells (Cho et al. 2011; Hayashi et al. 2008; Zhu et al. 2006). 
Moreover, preclinical studies documented that collagen membrane can allow early 
transmembranous anastomosis between the mucoperiosteal flap and the tissue below the 
membrane (Schwarz et al. 2009; Schwarz et al. 2006). In a previous preclinical study, CM 
was compared to collagenated DBBM as carrier for BMP-2 in GBR of horizontal defects 
(Chang et al. 2015). In this study BMP-2 loaded DBBM was covered with CM and compared 
with DBBM covered with BMP-2 loaded CM. The study found no differences in terms of new 
bone formation, and concluded that loading of CM with BMP-2 might represent a viable 
option for enhancing bone healing in onlay bone augmentations. 
Therefore, the aim of the present pilot study was to test whether a porcine-derived 
collagenated bone substitute block (PCBB) and CM loaded with BMP-2 used for horizontal 
ridge augmentation perform differently from PCBB and CM without BMP-2 with regard to the 
osseointegration of the grafting material and the maintenance of the ridge contour. 
 
Materials and methods 
This article was written in accordance with the ARRIVE guidelines (Kilkenny et al. 
2010). Prior to the beginning of the study, the protocol was approved by the Institutional 
Animal Care and Use Committee, Yonsei Medical Center, Seoul, Korea (approval no. 2013-
0317). The experimental part of this study was conducted from December 2013 to April 2014. 
Animals 
Six male adult beagle dogs (age 12 ± 3 months, mean weight 8 kg) (Gukje, Pocheon, 
Korea) were included in this study. All animals presented a fully erupted healthy permanent 
dentition. The dogs were subjected to surgeries and housed at the Department of Laboratory 
Animal Resources in Yonsei Biomedical Research Institute in Seoul of Korea. The dogs 
were monitored daily during the entire study period by an accredited veterinarian in the 
laboratory of animal sciences. The animals housed in separate cages were allowed to move 
freely under standard laboratory conditions at an average temperature of 21°C and relative 
humidity of 35% to 65%. During the study period, the animals were fed with canned soft dog 
food and water ad libitum. The trial began after a 4-week long adaption period for the 
animals.  
Materials for bone augmentation 
The following materials for bone augmentation were used in this study. 
Block: porcine-derived collagenated bone substitute block (PCBB) (Collaoss®, 
Bioland, Chungwon, Korea); dimensions 8 mm (length) x 5 mm (width) x 4 mm (height); rigid-
type bone substitute comprising 90-98% porcine bone and 2-10% cross-linked collagen. The 
pore size and the porosity were analyzed by a mercury intrusion porosimeter (AutoPore IV 
9500, Micromeritics Co. Ltd., Norcross, GA, USA). The average porosity of PCBB measured 
76.98%. The specific surface area amounted to 6.044 m2/g as assessed by nitrogen 
adsorption-desorption methodology (supplement Fig. 1). For the preparation of PCBB, 
cancellous-cortical porcine bone was deproteinized in 15% NaOH for 3 hours. The bone was 
sliced at a thickness of 5-10cm and placed in boiling water at 100°C for 72 hours. 
Subsequently, the bone was heated at 600°C for 10 hours to remove any protein and lipid. 
Processed bone blocks were placed in an aqueous dispersion of collagen. This mixture was 
poured into an aluminum mold and frozen at -40°C for 12 hours. The samples were then 
dehydrated for 24 hours under vacuum. The dehydration treatment was performed by 
placing the freeze-dried mixture in a vacuum oven (OV-02, JEIO TECH, Seoul, Korea) under 
a pressure of 1 mmHg to cross-link the collagen. The temperature of the samples returned to 
room temperature before removing the vacuum.  
Collagen membrane (CM): porcine cross-linked collagen membrane (Ossguide®; 
Bioland, Chungwon, Korea); dimensions 12.5 mm x 12.5 mm; type I collagen derived from 
porcine pericardium. After decellularization and removal of DNA, the collagen matrix was 
placed into a mold and freeze-dried. The cross-linking process was carried out in the same 
manner as for PCBB. 
rhBMP-2 (BMP2): 2 mg of rhBMP-2 (Cowellmedi, Busan, Korea) was mixed with 1.34 
ml of sterile water and diluted with 2.68 ml of buffer to produce a stock solution of rhBMP-2 
at a concentration of 0.5 mg/ml.  
Study design and randomization  
This investigation was designed as a randomized controlled trial with intra-subject 
control for the comparison of 4 treatment procedures. To avoid the local effect of BMP-2 on 
the sites without BMP-2, the sites with BMP-2 were allocated on one side of the mandible 
and the sites without BMP-2 on the contralateral side. The site allocations (left vs. right, 
anterior vs. posterior) were randomly determined by flipping a coin. 
The study was performed in 2 surgical phases including (i) tooth extraction and bone 
augmentation of acute-type defects (four defects per animal) and (ii) implant placement (one 
implant per defect).  
At the first surgical session, the bone defects were randomly allocated to receive one 
of the following treatment modalities:  
• Block: PCBB alone 
• Block+CM: PCBB + CM 
• Block-BMP2: PCBB loaded with rhBMP-2 (0.5mg/ml, 0.2ml) 
• Block+CM-BMP2: PCBB + CM loaded with rhBMP-2 (0.5mg/ml, 0.2ml) 
Surgical procedures  
The investigators participating in the study were experienced in implant placement 
and bone regeneration procedures. Plaque control program was initiated one week before 
the surgical procedure. All surgical procedures were performed under general anesthesia. 
The animals were premedicated with ketorolac trometamine (0.5 mg/kg/i.v. Keromin; Hana 
Pharmaceutical, Hwasung, Korea), enroflaxacin (5 mg/kg/i.v. and i.m. Baytril; Bayer Korea, 
Ansan, Korea) and cimetidine (5-10mg/kg/i.v.Cimetidine; Taiguk Pharmaceutical, Hwasung, 
Korea). General anesthesia was inducted by xylazine (2mg/kg/i.v. Rompun; Bayer Korea, 
Seoul, Korea) and ketamine hydrochloride (10 mg/kg/i.v. Ketalar; Yuhan, Seoul, Korea), and 
maintained by inhalation of an O2 and 1-2% isoflurane mixture (Forane; Choongwae 
Pharmaceutical, Seoul, Korea). A local anesthesia composed of 2% lidocaine with 1: 80’000 
epinephrine (Kwangmyung Pharmaceutical, Seoul, Korea) was used to reduce peri-operative 
pain and bleeding. During anesthesia, the dogs were monitored by a veterinarian by means 
of electrocardiography, capnography, pulsioxymetry, and blood pressure measurements. 
Postoperatively, antibiotics (amoxicillin 13 mg/kg/p.o. Moxicle; Boryung Pharmaceutical, 
Ansan, Korea) were administrated for 7 days. During the first two postoperative weeks, the 
oral mucosa and teeth were disinfected three times a week by irrigation of a 0.12% 
chlorhexidine solution (Hexamedine; Bukwang Pharmaceutical, Seoul, Korea).  
Surgery 1 (tooth extraction, defect preparation and bone augmentation) 
The mandibular third and fourth premolars were bilaterally sectioned by using fissure 
burs and extracted with elevators and forceps. Buccal and lingual mucoperiosteal flaps were 
elevated and two semi-saddle-type bone defects were prepared on each side of the 
mandible by removing the buccal wall of the alveoloar ridge. The box-shaped bone defects 
measured 8 mm mesio-distally, 4 mm apico-coronally, and 5 mm bucco-orally (Fig. 1a). 
One drilling with 2.2 mm-diameter was performed in each defect, in the site of the 
prospective implant placement. The center of the drilling was placed, mesio-distally, in the 
middle of the bone defect and, bucco-orally, along the lingual bone wall of the defect. Guide 
pins were inserted in the drill holes, and a pick-up impression was taken using light and 
heavy body silicone material (Exafine, GC Dental Products Corp, Japan) (Fig. 1b and 1c). 
PCBB for the treatment modalities Block and Block+CM was hydrated with sterile 
0.9% saline. For each of the sites Block-BMP2 and Block+CM-BMP2, 0.2 ml of 0.5 mg/ml 
rhBMP-2 solution were withdrawn by using a sterile 1-ml syringe and uniformly dispensed 
over the entire surface of PCBB and CM on a sterile dish. Following a 15-min loading time at 
room temperature, the rhBMP-2-loaded PCBB was applied to the assigned experimental site 
in the Block-BMP2 group, and the rhBMP-2-loaded CM was applied on PCBB in the 
Block+CM-BMP2 group. At the sites Block+CM and Block+CM-BMP2, CM was applied to 
cover the bone substitute and overlap the walls of the defect (Fig. 1d). No screws or pins 
were used for stabilization of blocks and membranes. The mucoperiosteal flaps were closed 
with resorbable sutures (Monosyn® 4-0; B Braun, Tuttlingen, Germany). The sutures were 
removed after 10 days and 12 weeks of healing were allowed. 
Surgery 2 (guided implant placement)  
Before the implant surgery, a cast was poured from the pick-up impression taken at 
the previous surgery. The model was scanned using an optical scanner (Trios, 3Shape, 
Copenhagen, Denmark) and the data were used to digitally design (OnDemand3D, 
Cybermed, Seoul, Korea) a tooth-supported surgical guide for the placement of implants 
along the original interface between the native bone and PCBB. A guide for static implant 
placement was produced by using a 3D printer (3Dent, EnvisionTEC, Germany).  
After 12 weeks of healing, a mid-crestal incision was performed and mucoperiosteal 
flaps were elevated. The condition of alveolar ridge was examined to assess whether the 
bone graft was integrated to allow implant placement. The surgical guide was applied onto 
the remaining dentition and used for static guided implant placement (Fig. 2a and 2b). Two 
cylindrical titanium bone level implants with acid-etched and sandblasted surface (NR line, 
Dentium, Seoul, Korea) were installed in each side of the mandible with implant shoulders at 
the level of alveolar bone crest. All the implants exhibited a diameter of 3.6 mm and a length 
of 9 mm. Cover screws were inserted and all implants were submerged for 8 weeks.  
Retrieval of specimens  
Eight weeks after implant placement, the animals were sedated with inhalation of 5% 
isoflurane (Forane; Choongwae Pharmaceutical, Seoul, Korea) and subsequently sacrificed 
with an overdose of potassium chloride (1.5 mg/kg/i.v. Potassium Chloride-40 Injection 
Daihan; Daihan Pharmaceutical, Seoul, Korea). The mandibles were block-resected 
including the surrounding soft tissues. 
Histological preparation  
Fixation of the specimens was performed in buffered 4% neutral formaldehyde 
solution. The specimens were dehydrated using ethanol solutions of increasing 
concentrations and subsequently embedded in a composite resin (Technovit 7200 VLC, 
Heraeus Kulzer, Hanau, Germany). One bucco-oral section through the central axis of the 
implant was prepared from each site. The tissue blocks were sectioned using a diamond 
cutting system (EXAKT 300 CP, EXAKT Apparatebau, Norderstedt, Germany) and the 
sections were ground and polished to a thickness of 35-45 µm (KULZER EXAKT 400CS, 
EXAKT Apparatebau, Norderstedt, Germany). The sections were stained with hematoxylin 
and eosin (Fig. 3). 
Histomorphometrical analysis  
Histomorphometrical analysis was performed by one investigator that was unaware of 
the specific experimental conditions. A digital color camera (Leica DFC 450, Leica 
Mikrosysteme, Wetzlar, Germany) connected to a light microscope (Microscope Leica 
DM6000, Leica Mikrosysteme) was used for image capturing. For histomorphometrical 
analysis, digital images were evaluated using an image analysis software (Leica Application 
Suite V4.3, Leica Mikrosysteme). 
For each section, the following variables were assessed:  
• the augmented area (AA) (mm2) within the former bone defect at the buccal 
aspect (Fig. 4) 
• the area of new mineralized bone (NB) (mm2) (primary outcome variable), 
residual bone substitute (BS) (mm2), and non-mineralized tissue (NMT) (mm2) 
within AA  (Fig. 4) 
• the apico-coronal distance (mm) between the apical margin of the former bone 
defect (DEF) and the most coronal level of bone in contact with the implant (DEF-
fBIC) (Fig. 5) 
• the apico-coronal distances (mm) between DEF and the most coronal level of 
new bone (DEF-NB), and between DEF and the most coronal level of bone 
substitute (DEF-BS) (Fig. 5) 
• the bucco-oral distances (mm) between the buccal implant surface (I) and the 
most buccal aspect of new bone (I-NB), and between I and the most buccal 
aspect of bone substitute (I-BS) (Fig. 5). 
Statistical analysis 
The animal was chosen as the unit for the statistical analysis. The data were reported 
by using means, standard deviations (SD), medians, and interquartile ranges (IQR) (SPSS 
software; SPSS Inc., Chicago, IL, USA). The Wilcoxon signed rank test was applied to detect 
differences between the treatments (R software; R Foundation, Vienna, Austria). The results 
of tests with P-values ≤ 0.05 were considered statistically significant. Due to the exploratory 
nature of this study, no sample size calculation and no correction for multiple testing were 
performed. 
 
Results 
Clinical findings 
Intraoperatively, PCBB permitted a press-fit mechanical anchorage within the box-
shaped defects without fracturing. All animals remained healthy during the entire study 
period. No systemic or local adverse events were observed. At reentry, PCBB was firmly 
integrated with the adjacent native bone and all the sites allowed implant placement along 
the interface between PCBB and native bone. 
Histological findings 
A total of 6 Block, 6 Block-BMP2, 6 Block+CM, and 6 Block+CM-BMP2 sites were 
available for the histological and the histomorphometrical analysis. All the implants were 
osseointegrated and presented with complete hard tissue coverage of the buccal surface 
intended for osseointegration. Bone ingrowth always reached the central portions of the 
blocks. New bone within the blocks mostly reached more buccally in comparison to the 
buccal contour of the native bone apical to PCBB. In the majority of the specimens, PCBB 
trabeculae did not reveal fractures or signs of resorption. 
Histomorphometrical findings 
Augmented area (AA) amounted to 10.4 ± 4.2 mm2 (SD) for Block, 11.8 ± 2.8 mm2 
(SD) for Block-BMP2, 9.8 ± 2.9 mm2 (SD) for Block+CM, and 8.5 ± 2.2 mm2 (SD) for 
Block+CM-BMP2 (Table 1, Fig. 6). Only the difference between Block-BMP2 and Block+CM-
BMP2 was statistically significant (P=0.031). 
New mineralized bone (NB) measured 2.3 ± 1.3 mm2 (SD) for Block, 2.0 ± 0.5 mm2 
(SD) for Block-BMP2, 2.7 ± 1.2 mm2 (SD) for Block+CM, and 1.8 ± 0.7 mm2 (SD) for 
Block+CM-BMP2 (Table 1, Fig. 6). There were no statistically significant differences between 
the treatment modalities (P > 0.05) (Table 1, Fig. 6). 
Residual bone substitute (BS) reached 3.7 ± 1.0 mm2 (SD) for Block, 6.1 ± 2.2 mm2 
(SD) for Block-BMP2, 3.4 ± 1.0 mm2 (SD) for Block+CM, and 3.4 ± 1.2 mm2 (SD) for 
Block+CM-BMP2 (Table 1, Fig. 6). Only the difference between Block-BMP2 and Block+CM 
was statistically significant (P=0.031). 
With regard to the distance between the most coronal level of bone in contact with 
the implant and the apical margin of the former bone defect (DEF-fBIC), the values 
amounted to 3.0 ± 0.6 mm2 (SD) for Block, to 2.7 ± 0.9 mm2 (SD) for Block-BMP2, to 3.0 ± 
0.9 mm2 (SD) for Block+CM, and to 2.3 ± 0.9 mm2 (SD) for Block+CM-BMP2 (Table 1). The 
results in DEF-fBIC did not differ significantly between the treatment modalities (P > 0.05). 
In terms of the most coronal and the most buccal localization of new bone (DEF-NB 
and I-NB) and residual bone substitute (DEF-BS and I-BS), there were no differences 
between the treatment modalities (P > 0.05) (Table 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
The results of the present study demonstrated that the addition of BMP-2 to PCBB or 
CM did not render a statistically significant improvement of their performance for horizontal 
ridge augmentation prior to implant placement. The treatment modalities did not significantly 
differ regarding the ridge contour and the new bone formation. PCBB with and without CM 
showed pronounced bone ingrowth and a capacity to maintain the augmented ridge contour. 
In all the augmented regions, the hard tissue was adequate to place implants along the 
former interface between the native bone and the grafting material. All the implants 
osseointegrated and presented with complete hard tissue coverage of the surface intended 
for osseointegration.  
The biologic activity and release kinetics of BMP-2 from porcine-derived particulated 
bone substitute was investigated in a previous in-vitro study (Yon et al. 2015). The results 
showed that an initial burst release of 40.8% occurred during the first three days. At 21 days, 
the cumulative release of BMP-2 reached 53.8% of the originally loaded dosis (Yon et al. 
2015). The release kinetics of BMP-2 from various carriers was evaluated in other studies 
(Draenert et al. 2013, Seeherman et al. 2002, Lee et al. 2016). It was reported that collagen 
has more BMP-2 loading capacity and an initial burst releasing property compared to 
hydroxyapatite. The PCBB used in this study comprised porcine-derived block bone 
substitute with an addition of cross-linked collagen. Therefore, a larger amount of BMP-2 
thought to be released from PCBB at initial stage compared to particulate bone mineral 
alone due to the effect of collagen included. The sustained release profile of PCBB is 
expected to be similar to that of particulated bone.  
There is a high level of preclinical and clinical evidence revealing that BMP-2 may 
stimulate bone regeneration and supporting the use of BMP-2 for ridge preservation, sinus 
floor elevation and horizontal ridge augmentation (Cha et al. 2014; Jung et al. 2015; Jung et 
al. 2008; Kim et al. 2015). However, there is no clinical and only scarce preclinical evidence 
for the use of BMP-2 in combination with xenogenic block bone substitutes for ridge 
augmentation. A previous preclinical study tested the use of DBBM blocks in combination 
with BMP-2 or GDF-5 for horizontal ridge augmentation (Schwarz et al. 2008). Chronic-type 
defects were horizontally augmented with 6 mm-thickness DBBM blocks alone or in 
combination with BMP-2 or GDF-5. DBBM blocks were loaded either with 2.3 ml of a 0.77 
mg/ml rhBMP-2 solution (1.77 mg rhBMP-2 per block) or with a rhGDF-5 solution. The 
control samples were moistened with sterile saline. All the blocks were screw-retained and 
covered with a CM. After 3 weeks of healing, there was very little bone ingrowth within 
DBBM blocks. At 8 weeks, DBBM blocks with BMP-2 and GDF-5 revealed significantly more 
new bone formation in comparison to DBBM blocks alone. The findings from this study 
contrast with the results of the present trial. The difference in the findings between the 
studies can be explained by the differences in defect model (present study: acute- versus 
previous study: chronic-type), bone substitute (PCBB versus DBBM), BMP-2 dose (0.1 
mg/block versus 1.77 mg/block), and time period between bone grafting and sacrifice (20 
weeks versus 8 weeks). The findings of the previously described study are in accordance 
with another study that demonstrated a beneficial effect of BMP-2 combined with DBBM for 
vertical bone augmentation (Kim et al. 2010). The onlay bone augmentation was performed 
in the cranial bone of rabbits by using DBBM blocks collagenated with 10% of porcine 
collagen (DBBM-collagen). DBBM-collagen was applied (1) alone, (2) covered with CM, or 
(3) loaded with BMP-2. After 12 weeks, the addition of BMP-2 and the use of barrier 
membranes rendered more favorable new bone formation in comparison to the control 
group. In the same study, in addition to DBBM, an allogenic cortico-cancellos bone block 
was investigated. In all the groups, the allograft block performed better than DBBM in terms 
of bone ingrowth and volume maintenance. Interestingly, the addition of BMP-2 to the 
allogenic block did not promote bone ingrowth in comparison to the allograft alone. In 
another preclinical study, DBBM blocks in combination with BMP-2 and/or VEGF were 
investigated for vertical bone augmentation in decorticated pig calvariae (Schmitt et al. 
2013). The growth factors mixed with fibrin glue were applied on the blocks. DBBM blocks 
were screw-retained without membrane coverage. The addition of BMP and/or VEGF did not 
reveal any promotional effect in the osseointegration. At 1 month, the percentage of bone 
volume within the total graft volume amounted to approximately 5%. At 2 months, this ratio 
reached about 10%. New bone was found in the peripheral portions of the block in contact 
with the native bone. The addition of BMP-2 to synthetic blocks was investigated in a recent 
preclinical study (Kim et al. 2012). In this study biphasic calcium phosphate blocks with or 
without collagen matrix were used for vertical bone augmentation in rabbit calvariae. The 
blocks with and without BMP-2 were screw-retained and no membranes were used. After 8 
weeks, the area of new bone was significantly greater in the specimens treated with BMP-2. 
The findings from the previously described investigations indicate that the effect of the BMP-
2 depends on the characteristics of the bone substitute. Previous investigation founds that 
the regenerative potential of growth and differentiation factors is dependent of a carrier 
material that serves as a delivery system and as a scaffold for cellular ingrowth (Hunt et al. 
2001; Sigurdsson et al. 1996). 
In the present study, PCBB with or without CM showed a pronounced 
osseointegration. Bone ingrowth always reached the central portions of the blocks. 
Moreover, new bone within the blocks mostly reached more buccally in comparison to the 
contour of the adjacent native ridge. Such a degree of osseointegration is surprising 
considered the lower osteoconductive capacity of bone substitute blocks in comparison to 
particulate grafting materials (Benic et al. 2016). Indeed, several previous preclinical 
investigations of xenograft blocks used for ridge augmentation revealed poor bone ingrowth 
within the blocks that were mostly embedded in fibrous tissue. In these studies DBBM blocks 
(Araujo et al. 2002; Benic et al. 2016; De Santis et al. 2012; Schmitt et al. 2013; Schwarz et 
al. 2008; Simion et al. 2006) and equine blocks of bone mineral with remnant collagen (Benic 
et al. 2016; Fontana et al. 2008; Schwarz et al. 2010; Simion et al. 2009), alone or in 
combination with CM, were used for horizontal and vertical bone augmentations. In a recent 
preclinical study, equine bone substitute blocks, DBBM blocks and DBBM granulate in 
combination with CM were used for the augmentation of large acute-type peri-implant 
defects (Benic et al. 2016). After 4 months of healing, the blocks showed more favorable 
results in the ridge contour in comparison to the particulate material. In terms of the surface 
fraction of bone substitute in contact with new bone, granulate reached higher values 
compared to the block materials. The difference between DBBM granulate and DBBM block 
reached statistical significance, indicating a superior osteoconductivity of particulate material 
in comparison to the block. It was hypothesized that the difference in the rate of bone 
ingrowth was due to the differences in the macrostructure, with particulate material 
facilitating ingrowth of blood vessels and new bone. It is important to emphasize that the 
results in new bone formation of the present study cannot be directly compared with the 
findings from other investigations of bone substitute blocks. This is due to the differences in 
multiple factors, such as defect localization, defect type, staging of augmentation, use of 
membrane, and time period allowed for healing. 
In the present trial, at all the sites the width of the augmented ridge allowed implant 
placement along the interface between the native bone and the grafting material without 
additional grafting. After 12 weeks, all the implants presented with complete hard tissue 
coverage of the surface intended for osseointegration. Despite the cross-sectional nature of 
the assessment in this study, based on the known initial dimensions of the block it can be 
deduced that PCBB with or without CM showed a capacity to maintain the augmented ridge 
contour. This finding can be explained by the mechanical stability of the block. 
Intraoperatively, the rigid-type block was not prone to fractures, therefore, permitting a press-
fit anchorage within the box-shaped defect. Moreover, an intact trabecular network and no 
fractures of the trabeculae were observed in the histologic specimens. The mechanical 
properties of PCBB can be explained by the proprietary fabrication process with chemic and 
thermal deproteinization, followed by an addition of collagen. Previous in-vitro and in-vivo 
preclinical studies showed the superior performance of bone substitute blocks over 
particulate materials regarding the contour maintenance after augmentation of non-contained 
bone defects (Benic et al. 2016; Mir-Mari et al. 2016; Schwarz et al. 2008). 
Another possible explanation for the capacity of PCBB to maintain the augmented 
contour might by its resistance to biodegradation. In the majority of the histologic samples, 
PCBB trabeculae did not reveal signs of resorption and the original block form appeared 
unchanged. It is known that deproteinized xenogenic bone substitutes, such as DBBM, 
resorb at a very slow rate (Mordenfeld et al. 2010; Shin et al. 2014). In contrast, 
investigations of an equine-derived bone substitute block with collagen remnants revealed 
pronounced signs of biomaterial resorption (Benic et al. 2016; Fontana et al. 2008; Schwarz 
et al. 2010). 
In this experiment, a model of an acute-type defect was used for ridge augmentation 
immediately after tooth extraction. The chronification of bone defects was omitted to 
standardize the initial defect dimension. This was done aiming at reproducible surgical 
procedure and histomorphometrical analysis. Consequently, the applied model did not 
ideally simulate the typical clinical situation of primary ridge augmentation at atrophic jaw 
regions. The missing sample size calculation and lack of correction for multiple testing 
represent additional shortcoming of the present pilot trial. 
The findings of the present study regarding the osseointegration of PCBB with and 
without BMP-2 need to be considered with caution due to the small sample size and the 
variability between the animals. Nevertheless, the clinical and the histologic performance of 
PCBB used for horizontal ridge augmentation are worth of reporting. In fact, the application 
of PCBB enabled a successful augmentation of bone defects and osseointegration of all 
implants in the previously augmented sites. This result is in accordance with a preclinical 
study and a clinical case series, in which xenogenic blocks were used for horizontal ridge 
augmentations (De Santis et al. 2012; Hammerle et al. 2008). Based on these observations, 
it can be concluded that xenograft blocks might represent a viable alternative to autogenous 
bone blocks for primary ridge augmentation. Further comparative preclinical trials are 
required to investigate the performance of different bone substitute blocks for ridge 
augmentation. The influence of bone augmentation with bone substitute blocks on the long-
term contour stability of the augmented ridge and the implant success should be examined in 
clinical studies.  
 
 
 
 
Conclusions 
Within the limitations of the present study, it can be concluded that for horizontal 
ridge augmentation with PCBB, alone or in combination with CM, prior to implant placement: 
• The addition of BMP-2 to PCBB and CM did not render a statistically significant 
improvement in the maintenance of the augmented ridge contour and the new 
bone formation. 
• PCBB showed pronounced bone ingrowth and a capacity to maintain the 
augmented ridge contour. 
• All the implants osseointegrated and presented with complete hard tissue 
coverage of the surface intended for osseointegration.  
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Figures legend 
Fig. 1. (a) Buccal view of the bone defects prior to bone augmentation. (b) Guide pins 
indicating the prospective implant positions along the lingual bone wall of the defect. (c) Pick-
up silicone impression with guide pins. (d) Horizontal ridge augmentation with porcine bone 
substitute block alone (right) and in combination with a collagen membrane (left). 
Fig. 2. (a) Surgical template for guided implant placement. (b) Occlusal view after 
implant placement. 
Fig. 3. Histological views: (a) porcine collagenated bone substitute block (PCBB) 
alone, (b) PCBB loaded with BMP-2, (c) PCBB covered with collagen membrane (CM), (d) 
PCBB covered with BMP-2 loaded CM. 
Fig. 4. Histomorphometrical assessments of (a) the augmented area (green line) and 
(b) the areas of new mineralized bone (yellow surface), residual bone substitute (red 
surface), and non-mineralized tissue (green surface) within the augmented area. 
Fig. 5. Histomorphometrical assessments of the distances between bone defect and 
most coronal bone-to-implant contact (DEF- fBIC), new bone (DEF-NB) and bone substitute 
(DEF-BS), and between implant surface and most buccal new bone (I-NB) and bone 
substitute (I-BS). 
Fig 6. Plots representing (a) the absolute values (in mm2) and (b) the relative values 
(in %) of new bone (NB), residual bone substitute (BS), and non-mineralized tissue (NMT) 
within the augmented area (AA) for different treatment modalities. 
Supplement Fig 1. Micro computed tomographic images of PCBB exhibiting a porous 
block form. (Left) Cross-sectional view, (Right) 3-dimensional reconstructed view. 
 
 
Table legend 
Table. 1. Results of the (a) histomorphometric analysis; (b) statistical tests for 
comparisons between the treatment modalities 
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Table 1a 
 
(a)   Treatment modality 
Parameter Unit 1. Block                    
(n=6) 
2. Block-BMP2         
(n=6) 
3. Block + CM          
(n=6) 
4. Block + CM-
BMP2 (n=6) 
    Mean ± SD                    
  (Q1, median, 
Q3) 
   
AA mm2 10.4 ± 4.2 11.8 ± 2.8 9.8 ± 2.9 8.5 ± 2.2 
    (6.8, 10.1, 13.7) (9.2, 11.9, 14.1) (7.7, 10.4, 12.0) (6.6, 8.0, 10.4) 
NB mm2 2.2 ± 1.3 2.0 ± 0.5 2.7 ± 1.2 1.8 ± 0.7 
    (1.1, 2.0, 3.2) (1.6, 2.1, 2.4) (1.6, 2.7, 4.0) (1.3, 1.8, 2.4) 
NB % 20.8 ± 5.9 17.2 ± 3.7 26.7 ± 8.0 21.3 ± 5.4 
    (14.1, 21.6, 26.0) (14.4, 15.5, 21.7) (17.1, 30.2, 32.6) (16.0, 22.5, 25.5) 
BS mm2 3.7 ± 1.0 6.1 ± 2.2 3.4 ± 1.0 3.4 ± 1.2 
    (2.9, 3.5, 4.2) (4.1, 5.4, 8.7) (2.5, 3.4, 4.2) (2.6, 3.2, 3.9) 
BS % 37.7 ± 9.8 50.8 ± 9.4 36.3 ± 8.1 40.5 ± 12.7 
    (29.7, 33.5, 49.7) (40.8, 52.6, 58.0) (28.9, 33.8, 44.8) (27.4, 39.5, 53.9) 
NMT mm2 4.5 ± 2.3 3.7 ± 0.9 3.6 ± 1.2 3.3 ± 2.0 
    (2.4, 4.8, 6.5) (2.7, 3.8, 4.6) (2.9, 3.6, 4.8) (1.6, 2.9, 4.8) 
NMT % 41.5 ± 10.5 32.0 ± 6.8 37.0 ± 3.4 38.2 ± 17.4 
    (34.4, 39.7, 51.2) (27.1, 32.8, 37.4) (33.4, 37.7, 40.0) (22.3, 36.8, 56.6) 
DEF-fBIC mm 3.0 ± 0.6 2.7 ± 0.9 3.0 ± 0.9 2.3 ± 0.9 
    (2.4, 3.0, 3.7) (2.1, 2.6, 3.4) (2.1, 3.3, 3.6) (1.4, 2.4, 3.2) 
DEF-NB mm 4.4 ± 0.6 4.1 ± 1.0 3.9 ± 0.8 3.4 ± 1.1 
    (4.0, 4.3, 4.8) (3.4, 4.5, 4.9) (3.2, 4.0, 4.6) (2.1, 3.8, 4.3) 
DEF-BS mm 4.8 ± 0.5 4.9 ± 0.3 4.6 ± 0.7 4.2 ± 0.7 
    (4.4, 4.8, 5.2) (4.5, 4.9, 5.2) (3.8, 4.7, 5.2) (3.8, 4.5, 4.6) 
I-NB mm 2.3 ± 1.0 2.5 ± 0.7 2.2 ± 0.8 2.1 ± 0.6 
    (1.4, 2.2, 3.1) (2.0, 2.4, 3.0) (1.6, 2.3, 2.8) (1.4, 2.3, 2.5) 
I-BS mm 2.6 ± 1.0 2.8 ± 0.6 2.6 ± 0.9 2.6 ± 0.5 
    (1.7, 2.6, 3.4) (2.4, 2.8, 3.2) (1.9, 2.6, 3.3) (2.2, 2.8, 3.0) 
 
  
 
Table 1b 
 
(b) Statistical analysis* 
  
  
  
  
Parameter 1 v.s 2 1 vs. 3 1 vs. 4 2 vs. 3 2 vs. 4 3 vs. 4 
AA 0.563 0.844 0.313 0.156 0.031† 0.219 
NB 0.840 0.560 0.310 0.160 1.000 0.160 
NB (%) 0.156 0.094 0.438 0.068 0.068 0.313 
BS 0.094 1.000 0.688 0.031† 0.156 1.000 
BS (%) 0.031† 0.313 1.000 0.031† 0.219 0.688 
NMT 0.310 0.560 0.160 1.000 0.310 0.840 
NMT (%) 0.160 0.440 0.840 0.310 0.560 1.000 
DEF-fBIC 0.563 1.000 0.094 0.438 0.688 0.156 
DEF-NB 0.560 0.160 0.160 1.000 0.440 0.690 
DEF-BS 0.590 1.000 0.219 1.000 0.063 0.438 
I-NB 0.440 0.690 0.440 0.310 0.160 1.000 
I-BS 0.690 0.840 0.690 0.690 0.560 1.000 
AA, augmented area; NB, new mineralized bone; %, percentage of AA; BS, bone substitute; NMT, 
non-mineralized tissue; DEF-fBIC, apico-coronal distance between the apical margin of the former 
bone defect and the most coronal level of bone in contact with the implant; DEF-NB, apico-coronal 
distance between the apical margin of the former bone defect and the most coronal level of new bone; 
DEF-BS, apico-coronal distance between the apical margin of the former bone defect and the most 
coronal level of bone substitute;  I-NB, bucco-oral distance between the buccal implant surface and 
the most buccal aspect of new bone; I-BS; bucco-oral distance between the buccal implant surface 
and the most buccal aspect of new bone; SD, standard deviation; Q1, first quartile; Q3, third quartile; 
*, results of repeated Wilcoxon signed rank test; †, statistically significant 
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